The chart below shows how WBA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, WBA sees a -0.82% change in stock price 10 days leading up to the earnings, and a -3.29% change 10 days following the report. On the earnings day itself, the stock moves by +1.88%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Sales Growth Overview: Sales increased 6.9% on a constant currency basis with growth across all segments.
Decline in Adjusted EPS: Adjusted EPS of $0.51 declined 23% year over year and on a constant currency basis.
Pharmacy Market Share Stability: In U.S. pharmacy, we maintained script market share.
International Business Performance: Our international business continued to show strong returns, and our U.S. health care segment contributed somewhat above expectations on a combination of revenue growth and cost control.
Long-Term Turnaround Progress: We started to progress on the opportunities that we consider essential to our longer-term turnaround.
Negative
Decline in Adjusted EPS: Adjusted EPS of $0.51 declined 23% year over year and on a constant currency basis.
Net Earnings Adjustments: GAAP net earnings for the first quarter included after-tax charges of $252 million related to the footprint optimization program, and $152 million non-cash charge related to fair value adjustments on variable prepaid forward derivatives.
Retail Sales Decline: Comparable retail sales declined 4.6% in the quarter, which was lower than our expectations.
Pharmacy Sales Dynamics: Comparable sales growth in the pharmacy segment was offset by lower retail sales, partly due to continued cost discipline.
Seasonal Impact on Retail: The warmer season impacted our first-quarter results with reduced respiratory incidence and the associated baskets contributing to about half of our retail decline versus last year.
Walgreens Boots Alliance, Inc. (WBA) Q1 2025 Earnings Call Transcript
WBA.O
1.33%